Biaxin Linked To Increased Risk Of Bleeding Compared to Zithromax: Study

Side effects of the antibiotic Biaxin may increase the risk of serious bleeding problems, especially when given in conjunction with some blood thinners, according to the findings of new research.

In a study published earlier this week in the medical journal JAMA Internal Medicine, Canadian researchers looked at the risk of hospitalization due to bleeding problems when Biaxin (clarithromycin) or Zithromax (azithromycin) were used at the same time as direct oral anticoagulants (DOAC). They found that Biaxin users faced a more than 70% increased risk of bleeding problems.

According to the researchers, Biaxin patients are commonly found to be taking blood thinners at the same time, which raised concerns about an increased risk of hemorrhaging. As a result, they sought out to assess the 30-day risk of hospital admission due to bleeding events among older patients taking Biaxin with blood thinners.

Did You Know? Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

To do so, researchers conducted a population-based, retrospective cohort study of patients with a mean age of 77.6 years. The study involved nearly 6,600 patients newly co-prescribed Biaxin and more than 18,300 patients newly co-prescribed Zithromax or a similar azithromycin-based antibiotic who were also taking either Xarelto, Pradaxa or Eliquis. The study involved patients from Ontario, Canada from June 23, 2009, through December 31, 2016.

According to the findings, both antibiotics appeared to increase the risk of hospitalization due to hemorrhaging within 30 days of beginning treatment. However, Biaxin was linked to a 71% higher risk than azithromycin.

“This study suggests that, among adults of advanced age taking a DOAC, concurrent use of clarithromycin compared with azithromycin was associated with a small but statistically significantly greater 30-day risk of hospital admission with major hemorrhage,” the researchers concluded.

The researchers found that the most commonly prescribed blood thinner was Xarelto.

Biaxin and other clarithromycin antibiotics are used to treat a wide range of infections, including those affecting the lungs, skin, ears and sinuses.Both Biaxin and Zithromax belongs to a class of antibiotics known as macrolides.

Both antibiotics have been previously linked to an increased risk of heart problems.

In January 2016, a study published by researchers from Hong Kong found that the risk of heart attacks was more than double among Biaxan users, compared to those given amoxicillin. A similar study published in 2013 also found an increased risk of Biaxin heart problems among patients with chronic obstructive pulmonary disease (COPD).

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Direct Filing of NEC Lawsuits Against Similac, Enfamil Manufacturers To Be Permitted in MDL
Direct Filing of NEC Lawsuits Against Similac, Enfamil Manufacturers To Be Permitted in MDL (Posted 6 days ago)

A federal judge plans to approve direct filing of future NEC lawsuits straight to the MDL court, streamlining the process for parents pursuing claims against the makers of Similac and Enfamil cow's milk-based formula.